COMMUNIQUÉS West-GlobeNewswire

Sironax Named to Fierce Biotech’s “Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026
05/10/2026
Recognized for bold approach to addressing therapeutic targets WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for [...]
Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension
05/10/2026
Two oral presentations at AHA Hypertension 2026 will highlight the substantial antihypertensive efficacy of aprocitentan in two hypertension populations from the PRECISION study: patients with obesity and patients [...]
Déclaration d’actions et de droits de vote - Statut au 30 septembre 2026
05/10/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 30 septembre 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège [...]
Declaration of shares and voting rights - Status as of September 30, 2026
05/10/2026
VALNEVA Declaration of shares and voting rights Status as of September 30, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot [...]
Global Alzheimer's Platform Foundation Names New Medical Director at Tampa Research Site
05/10/2026
WASHINGTON, D. C. , Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform Foundation ® (GAP), announced today that Dr. Jeffery Greenberg is joining GAP as the Medical Director and Principal Investigator of [...]
Zealand Pharma – Completion of share buy-back program and related transactions (week 40 and 41, 2026)
05/10/2026
Company announcement No. 53 / 2026 Zealand Pharma - Completion of share buy-back program and related transactions (week 40 and 41, 2026) Copenhagen, Denmark, October 5, 2026 – Zealand Pharma A/S ("the Company" or “ [...]
Frederick Breathe Free Celebrates Dr. Jamie Oberman’s Recognition as a 2026 Castle Connolly Top Doctor
05/10/2026
Dr. Oberman’s recognition highlights his commitment to thoughtful, patient-centered ENT care at Frederick Breathe Free. Frederick, MD, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Frederick Breathe Free Sinus & Allergy Centers [...]
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
05/10/2026
Multi-year expansion of the companies’ 2025 agreement to use Gate’s Molecular Gate drug discovery engine to design molecular gate medicines for Lilly targets BRISBANE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Gate [...]
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
05/10/2026
Constructive FDA interaction provides clear framework for RAD101 pivotal clinical development plan in brain metastases imaging Currently executing Phase 3 readiness activities in anticipation of FDA meeting minutes in [...]
Cannara Expands International Supply Agreement with Curaleaf
05/10/2026
MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, the “ Company ”, “ us ” or “ we ”) ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026
05/10/2026
Oncotelic’s AI drug discovery platform invites scientists, developers and biotech founders to connect computational discovery with drug development. Source: Oncotelic Therapeutics, Inc. AGOURA HILLS, Calif., Oct. 05, [...]
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
05/10/2026
ORION CORPORATION PRESS RELEASE 05 OCTOBER 2026 at 8:00am ET Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing Milestone [...]
Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026
05/10/2026
Rapid oral presentation of additional sub-group analyses from the VIKTORIA-1 PIK3CA mutant-type cohort Poster presentation of a comparative analysis of data for the gedatolisib triplet from the PIK3CA wild-type cohort [...]
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
05/10/2026
Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, compared to the daily [...]
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
05/10/2026
– Expands patient access to opioid-sparing pain control and advances 5x30 strategy – BRISBANE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to [...]
Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
05/10/2026
~ Acceptance into ETP enables early FDA engagement to support development of the RaniPill® platform technology ~ SAN JOSE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a [...]
vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
05/10/2026
Milestone advances Phase 3 program toward topline results expected in mid 2027 HIGH POINT, N.C., Oct. 05, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing [...]
Sofwave to Participate in the Jefferies Private MedTech Virtual Summit
05/10/2026
SAN CLEMENTE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today [...]
Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026
05/10/2026
Presentations include real-world XPHOZAH® (tenapanor) data and new insights into hyperphosphatemia management and outcomes WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial- [...]

Pages